OpenFilings

Akebia Therapeutics, Inc.

Form10-K

Report Period2023-12-31

Date Filed2024-03-14

Time Filed17:19:06

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

10-K
EX-4.7
EX-10.21
EX-10.43
EX-10.44
EX-10.45
EX-10.46
EX-10.47
EX-10.66
EX-10.67
EX-10.93
EX-10.102
EX-10.103
EX-23.1
EX-31.1
EX-31.2
EX-32.1
EX-97.1
Filing on SEC Edgar